Specificity and host range |
Generally specific to one bacterial species (or strains within a species). Limited impact on microbiota composition. |
Narrow or broad depending on the chemical structure of the targeted macromolecule. Limited impact on microbiota composition. |
Mode of action |
Bacteriolytic activity depends on the titer, multiplicity of infection (MOI), burst size and propagation rate. |
Bacteriolytic activity depends on concentration and minimum inhibitory concentration (MIC). |
Resistance development |
Resistance developed by mutation, receptor modification, passive adaptation, restriction-modification, CRISPR-Cas, pseudolysogeny. |
Bacteria are less likely to develop resistance to endolysins. |
Stability |
Stability properties dependent on structural protein composition. |
Endolysins have a short half-life, but effectively work in short duration due to the rapid mode-of-action. |
Antibiofilm activity |
Relatively effective with limited penetration capacity. |
Effective against biofilms with higher penetration capacity. |
Inflammatory response |
Reticuloendothelial system (RES) clearance and immunogenic. |
Immunogenic, induction of antibody production. |
Pharmacokinetics |
Not properly defined, self-replicating and can be cleared by immune system. |
Evaluated in some endolysins; chemical structure affects penetration, plasma protein binding, and proteolysis degradation. |
Combined therapy |
Synergistic effect possible such as: phage cocktails, phage-protein and antibiotic–phage–protein combination. |
Synergistic effect between two endolysins with different catalytic specificities or between an endolysin and an antibiotic. |